Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 3,4 Dihydroxyphenylacetic Acid
2. 3,4-dihydroxyphenylacetic Acid, Monosodium Salt
3. Dopac
4. Homoprotocatechuic Acid
1. 102-32-9
2. Dopac
3. 2-(3,4-dihydroxyphenyl)acetic Acid
4. Homoprotocatechuic Acid
5. Dopacetic Acid
6. 3,4-dihydroxybenzeneacetic Acid
7. Benzeneacetic Acid, 3,4-dihydroxy-
8. Dihydroxyphenylacetic Acid
9. (3,4-dihydroxyphenyl)acetic Acid
10. Homoprotocatechuate
11. Acetic Acid, (3,4-dihydroxyphenyl)-
12. 3,4-dihydroxy-phenylacetic Acid
13. 3,4-dihydroxyphenylacetate
14. Ba 2773
15. 3,4-dihydroxyphenylaceticacid
16. Mfcd00004338
17. Lopac-d-9128
18. Kex5n0r4n5
19. 3,4-dhpop
20. Mls001056737
21. 3,4-dihydroxyphenyl Acetic Acid
22. Chebi:41941
23. Nsc-73191
24. 3,4-dihydroxyphenylcaetic Acid
25. Smr000326727
26. 4-carboxymethylcatechol
27. Dhy
28. 3,4-dihydroxyphenylacetate, Xv
29. 2-(3,4-dihydroxyphenyl)acetate
30. Ccris 3765
31. Catechol-4-acetic Acid
32. Einecs 203-024-1
33. Nsc 73191
34. Unii-kex5n0r4n5
35. Brn 2211017
36. Dopacetate
37. Ai3-52339
38. 3pcn
39. Dihydroxyphenylacetate
40. 1ai4
41. Cid_547
42. 4-carboxymethylpyrocatechol
43. Bmse000329
44. Pyrocatechol-4-acetic Acid
45. 3,4-dihydroxybenzeneacetate
46. Chembl1284
47. Nciopen2_000518
48. Lopac0_000414
49. Schembl36348
50. Benzeneacetic Acid,4-dihydroxy-
51. Dtxsid9074430
52. Acetic Acid,4-dihydroxyphenyl)-
53. Bdbm52946
54. Hmdb01336
55. 3,4-dihydroxy-benzeneacetic Acid
56. 3,4-dihydroxyl Phenylacetic Acid
57. Hms2233i20
58. Hms3261c10
59. Hms3373a01
60. Kuc106695n
61. Kuc106697n
62. Zinc388555
63. (3,4-dihydroxyphenyl)-acetic Acid
64. Nsc73191
65. Tox21_500414
66. S5639
67. 3,4-dihydroxyphenylacetic Acid, 98%
68. Akos015890264
69. 3,4-dihydroxyphenylacetic Acid Polymer
70. Ac-5292
71. Ccg-204506
72. Cs-w001080
73. Db01702
74. Dopac/(3,4-dihydroxyphenyl)-aceticaci
75. Hy-w001080
76. Lp00414
77. Rs-1018
78. Sdccgsbi-0050399.p002
79. Acetic Acid, (3,4-dihydroxyphenyl)-,
80. Ncgc00015381-01
81. Ncgc00015381-02
82. Ncgc00015381-03
83. Ncgc00015381-04
84. Ncgc00015381-05
85. Ncgc00015381-06
86. Ncgc00093838-01
87. Ncgc00093838-02
88. Ncgc00093838-03
89. Ncgc00261099-01
90. Haa
91. Ksc-11-207-5
92. Ksc-11-207-8
93. Sy015718
94. 2-[3,4-bis(oxidanyl)phenyl]ethanoic Acid
95. Am20020093
96. D1283
97. Eu-0100414
98. Ft-0614331
99. 3,4-dihydroxyphenylacetic Acid-[13c,18o2]
100. C01161
101. D 9128
102. A800559
103. Sr-01000075841
104. 3,4-dihydroxyphenylacetic Acid, Analytical Standard
105. J-000672
106. Q4634071
107. Sr-01000075841-1
108. 47115c80-8c82-419a-bc51-b10a2cb7fe8f
| Molecular Weight | 168.15 g/mol |
|---|---|
| Molecular Formula | C8H8O4 |
| XLogP3 | 0.5 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 2 |
| Exact Mass | 168.04225873 g/mol |
| Monoisotopic Mass | 168.04225873 g/mol |
| Topological Polar Surface Area | 77.8 Ų |
| Heavy Atom Count | 12 |
| Formal Charge | 0 |
| Complexity | 168 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
3,4-dihydroxyphenylacetic acid has known human metabolites that include 3-hydroxyphenylacetic acid, 4-hydroxyphenylacetic acid, and Protocatehuic acid.
3,4-dihydroxyphenylacetic acid is a known human metabolite of Cyanidin.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
ABOUT THIS PAGE
A 3,4-Dihydroxyphenylacetic Acid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 3,4-Dihydroxyphenylacetic Acid, including repackagers and relabelers. The FDA regulates 3,4-Dihydroxyphenylacetic Acid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 3,4-Dihydroxyphenylacetic Acid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 3,4-Dihydroxyphenylacetic Acid supplier is an individual or a company that provides 3,4-Dihydroxyphenylacetic Acid active pharmaceutical ingredient (API) or 3,4-Dihydroxyphenylacetic Acid finished formulations upon request. The 3,4-Dihydroxyphenylacetic Acid suppliers may include 3,4-Dihydroxyphenylacetic Acid API manufacturers, exporters, distributors and traders.
3,4-Dihydroxyphenylacetic Acid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 3,4-Dihydroxyphenylacetic Acid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 3,4-Dihydroxyphenylacetic Acid GMP manufacturer or 3,4-Dihydroxyphenylacetic Acid GMP API supplier for your needs.
A 3,4-Dihydroxyphenylacetic Acid CoA (Certificate of Analysis) is a formal document that attests to 3,4-Dihydroxyphenylacetic Acid's compliance with 3,4-Dihydroxyphenylacetic Acid specifications and serves as a tool for batch-level quality control.
3,4-Dihydroxyphenylacetic Acid CoA mostly includes findings from lab analyses of a specific batch. For each 3,4-Dihydroxyphenylacetic Acid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
3,4-Dihydroxyphenylacetic Acid may be tested according to a variety of international standards, such as European Pharmacopoeia (3,4-Dihydroxyphenylacetic Acid EP), 3,4-Dihydroxyphenylacetic Acid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (3,4-Dihydroxyphenylacetic Acid USP).
LOOKING FOR A SUPPLIER?
